Could a 10-second speech test repeating “pa,” “ta,” “ka” be the key to earlier detection of Alzheimer’s risk? Our new research suggests it might.
Pain is deeply personal, yet universally expressed through speech. But what if speech isn’t just a way we describe pain, but also a tool to measure and even modulate it?
A new study published in the European Journal of Human Genetics provides the first systematic analysis of speech and language difficulties in individuals with KIF1A-associated neurological disorder (KAND).
A major collaborative paper published in Alzheimer’s & Dementia introduces a critical roadmap for the development of digital health technologies (DHTs) tailored to the needs of individuals with frontotemporal degeneration (FTD).
Redenlab announces landmark study in collaboration with Queensland Institute of Medical Research